Click here for full US Prescribing Information including BOXED WARNING.
Learn more about Linzess®
Clinical Trial Transparency and Data Sharing
Ironwood is committed to sharing the results of our clinical
Linzess® (linaclotide) capsules for oral use
Please see full LINZESS Prescribing Information below and a website dedicated to providing you with product-specific information.
In order to monitor the safety of our product, we encourage reporting any side effects experienced while taking LINZESS to AbbVie at 1-800-678-1605. Alternatively, you can report any side effects of prescription drugs directly to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.
Clinical Trial Transparency and
Copyright © 2021, Ironwood Pharmaceuticals, Inc. All Rights Reserved
LINZESS®, CONSTELLA®, IRONWOOD® and their associated logos are trademarks of Ironwood Pharmaceuticals, Inc. Any other trademarks referred to herein are the property of their respective owners. All rights reserved.